JP Stock MarketDetailed Quotes

4503 Astellas Pharma

Watchlist
  • 1487.0
  • -26.5-1.75%
20min DelayMarket Closed May 17 15:00 JST
2.67TMarket Cap27.49P/E (Static)

Astellas Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Astellas Pharma Earnings Date

Currency: JPY

Period

FY2024 Annual Report

Apr 25, 2024

Revenue(YoY)

1.60T

+5.60%
NI to Common Holders(YoY)

17.05B

-82.73%
Analyst Rating

Buy

May 15, 2024

Astellas Pharma Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: JPY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 426.825B--
--2025/Q1-- / 411.043B--
Apr 25, 20242024/Q4414.602B / 381.093B--
Feb 5, 20242024/Q3421.932B / 385.383B--
Nov 1, 20232024/Q2392.148B / 355.602B--
Aug 1, 20232024/Q1374.990B / 357.906B--
Apr 27, 20232023/Q4354.254B / 361.045B--
Feb 6, 20232023/Q3402.180B / 395.900B--
Oct 31, 20222023/Q2380.394B / 360.355B--
Aug 1, 20222023/Q1381.791B / 345.350B--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 426.825B--
--2025/Q1-- / 411.043B--
Apr 25, 20242024/Q4414.602B / 381.093B--
Feb 5, 20242024/Q3421.932B / 385.383B--
Nov 1, 20232024/Q2392.148B / 355.602B--
Aug 1, 20232024/Q1374.990B / 357.906B--
Apr 27, 20232023/Q4354.254B / 361.045B--
Feb 6, 20232023/Q3402.180B / 395.900B--
Oct 31, 20222023/Q2380.394B / 360.355B--
Aug 1, 20222023/Q1381.791B / 345.350B--

Unlock Free Earnings Estimates

Astellas Pharma Earnings Reports

  • Astellas Pharma: Financial results briefing materials for the fiscal year ending March 2024

    Apr 25 01:00

  • Astellas Pharma: Supplemental Financial Results for the Fiscal Year Ending March 2024

    Apr 25 01:00

  • Astellas Pharma: Summary of financial results for the fiscal year ending March 31, 2024 [IFRS] (consolidated)

    Apr 25 01:00

  • Astellas Pharma: Revision of full-year earnings forecasts with recorded fair value fluctuations relating to conditional compensation for impairment losses of intangible assets

    Apr 12 02:00

    • Read more

    Analysis

    Analyst Rating

    Updated: May 15, 2024

    Buy

    • Strong Buy

      50.00%

    • Buy

      12.50%

    • Hold

      31.25%

    • Underperform

      6.25%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    JP
    Overall
    Symbol
    Latest Price
    %Chg